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Abstract
AIM: To test whether a new rinse solution containing 
polyethylene glycol 35 (PEG-35) could prevent isch-
emia-reperfusion injury (IRI) in liver grafts.
METHODS: Sprague-Dawley rat livers were stored 
in University of Wisconsin preservation solution and 
then washed with different rinse solutions (Ringer’s 
lactate solution and a new rinse solution enriched with 
PEG-35 at either 1 or 5 g/L) before ex vivo  perfusion 
with Krebs-Heinseleit buffer solution. We assessed the 
following: liver injury (transaminase levels), mitochon-
drial damage (glutamate dehydrogenase activity), liver 
function (bile output and vascular resistance), oxidative 
stress (malondialdehyde), nitric oxide, liver autophagy 
(Beclin-1 and LCB3) and cytoskeleton integrity (filament 
and globular actin fraction); as well as levels of metal-
loproteinases (MMP2 and MMP9), adenosine mono-
phosphate-activated protein kinase (AMPK), heat shock 
protein 70 (HSP70) and heme oxygenase 1 (HO-1).
RESULTS: When we used the PEG-35 rinse solution, 
reduced hepatic injury and improved liver function were 
noted after reperfusion. The PEG-35 rinse solution pre-
vented oxidative stress, mitochondrial damage, and 
liver autophagy. Further, it increased the expression of 
cytoprotective heat shock proteins such as HO-1 and 
HSP70, activated AMPK, and contributed to the restora-
tion of cytoskeleton integrity after IRI.
CONCLUSION: Using the rinse solution containing 
PEG-35 was effective for decreasing liver graft vulner-
ability to IRI.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
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Core tip: Research into optimal rinse solutions for 
graft washout is limited, and their clinical application 
is dependent on surgeon preference. We present a 
new rinse solution containing polyethylene glycol 35 
(PEG-35) that is not only suitable for washing liver 
grafts after cold preservation, but also provided good 
graft protection against reperfusion injury. Using 
PEG-35 in the rinse solution resulted in less hepatic in-
jury, a significant induction of cytoprotective proteins, 
and the preservation of cytoskeletal integrity. Thus, 
PEG-35 supplemented rinse solutions may contribute 
to liver graft protection against ischemia-reperfusion 
injury.
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INTRODUCTION
Liver transplantation (LT) has had a profound impact on 
patient outcomes in end-stage liver disease, representing 
the most effective treatment for many patients with acute 
or chronic liver failure[1]. Ischemia-reperfusion injury (IRI) 
is an inherent risk of  LT, and is often responsible for 
early graft failure within the first week of  surgery[2-4]. IRI 
is initiated when the liver is recovered from the donor 
and placed in cold storage solution; it continues when 
the graft is re-warmed prior to LT, and persists at graft 
revascularization after LT[3,4]. Research has identified sev-
eral strategies to reduce the impact of  these multifactorial 
processes on graft function.
Maintaining organ viability during cold storage (i.e., 
preservation) is an important prerequisite for a succes-
sful outcome after LT[1,5]. For this reason, the compo-
sition of  organ preservation solutions is crucial; during 
cold storage, the solution must prevent cell swelling, 
impaired energy metabolism, acidosis, and the accumu-
lation of  precursors of  reactive oxygen intermediates[1,5]. 
Currently, the University of  Wisconsin (UW) solution is 
the one most commonly used for LT[6,7]. However, seve-
ral studies have reported that its composition is limited 
by: (1) the high concentration of  K+ ions in preserved 
grafts that could cause cardiac arrest in the recipient at 
reperfusion[8]; (2) the oncotic agent, hydroxyl-ethyl starch 
(HES), which confers high viscosity with incomplete 
distribution of  the UW solution in the liver graft, parti-
cularly between the intravascular space and liver paren-
chyma; and (3) the hyper-aggregating effects of  HES 
on erythrocytes, which may hamper liver graft reperfu-
sion[9-11]. These limitations have led physicians to rinse 
grafts before revascularization to remove the K+ ions, 
HES, and toxins that accumulate during preservation, 
and to ensure optimal conditions for graft revasculariza-
tion and viability.
Current studies on rinse solutions for organ washout 
are limited. Ringer’s lactate solution (RLS) was initially 
used, before a more effective alternative was proposed 
by Adam et al[12] who used a macromolecular albumin so-
lution to restrict reperfusion damage. Later, the Carolina 
rinse solution was shown to prevent IRI[13-15], but it has a 
complex composition and contains HES, which induced 
red blood cell aggregation and incomplete washout[11]. 
Despite some reductions in liver injury, the optimal was-
hout solution has yet to be established and current prac-
tice depends mostly on physician preference.
In previous studies, we have used polyethylene glycol 
(PEG) 35 as an oncotic agent in Institut Georges Lopez 
(IGL-1) preservation solutions for liver graft conserva-
tion[16-18]. PEG-35 is a non-toxic, water-soluble polymer 
that prevents red blood cell aggregation when compared 
to HES[1,11]. PEG has shown protective effects in diffe-
rent organs and can reduce oxidative stress through the 
preservation or restoration of  membrane integrity[19]. 
Moreover, several studies have demonstrated the efficien-
cy of  PEG in kidney[20], heart[21], liver[22], pancreas[23], and 
small bowel[24] preservation in experimental models and 
clinical studies.
In the present study, we investigated the efficacy of  
liver washout with a new PEG-35 rinse solution after 
graft cold preservation in UW solution.
MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats (250 g body weight) were 
anesthetized under isoflurane inhalation according to Eu-
ropean Union regulations (Directive 86/609 EEC), and 
surgery was performed as previously reported[25]. Animals 
were randomly distributed into groups as described be-
low.
Liver washout
After 24 h cold storage in UW solution, the liver grafts 
were subjected to normothermic washout with different 
rinsing solutions (Table 1 and Table 2) and then re-per-
fused for 2 h at 37 ℃. The experimental groups were as 
follows: Group 1, Ringer’s lactate solution (RLS) (n = 8) 
as shown in Table 1; the liver grafts were flushed with 
RLS (15 min; room temperature) and then re-perfused 
for 2 h at 37 ℃. Group 2, Base solution (BS) (n = 8); 
same as Group 1, but flushed with the BS, as indicated in 
Table 2. Group 3, (BS + PEG1) (n = 8); same as Group 1, 
but flushed with BS supplemented with PEG-35 at 1 g/L 
(Table 2). Group 4, (BS + PEG5) (n = 8); same as Group 
1, but flushed with the BS supplemented with PEG-35 at 
5 g/L (Table 2).
Model of isolated perfused rat liver
After cold storage in UW solution, the liver grafts were 
rinsed at room temperature for 15 min using one of  the 
rinse solutions indicated above. Then livers were con-
nected via the portal vein to a recirculating perfusion 
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system for 2 h at 37 ℃. Time zero was the point at which 
the portal catheter was satisfactorily connected to the 
circuit. As previously reported, during the first 15 min 
of  perfusion (initial equilibration period), the flow was 
steadily increased until we achieved stabilization of  the 
portal pressure at 12 mm Hg (Pressure Monitor BP-1; 
World Precision Instruments, Sarasota, Florida). The flow 
was controlled by a peristaltic pump (Minipuls 3; Gilson, 
France)[26,27]. The reperfusion liquid consisted of  a cell 
culture medium (William’s medium E; Bio Whittaker, 
Barcelona, Spain) with a Krebs-Heinseleit-like electrolyte 
composition enriched with 5% albumin for oncotic pres-
sure[28]. Before entering the liver, the buffer was exposed 
to a mixture of  95% O2 and 5% CO2, a heat exchanger 
(37 ℃), and a bubble trap[27,28]. During normothermic re-
perfusion lasting 120 min, the effluent was collected at 30 
min intervals to measure the liver aminotransferase levels 
and the liver function (bile, vascular resistance). Biochem-
ical parameters were measured 2 h after reperfusion.
Biochemical determinations
Transaminase assay: Hepatic injury was assessed by 
measuring transaminase levels using commercial kits 
from RAL (Barcelona, Spain). Briefly, 200 μL of  effluent 
perfusate was added to the substrate provided by the 
commercial kit and the levels of  aspartate aminotrans-
ferase (AST) and alanine aminotransferase (ALT) were 
determined at 365 nm with an ultraviolet spectrometer 
and calculated according to the manufacturer’s instruc-
tions[27,29].
Bile Output: Liver function was assessed by measuring 
bile production. Bile was collected through a cannulated 
bile duct and output was reported as microliter per gram 
of  liver (μL/g liver)[26].
Vascular resistance: Liver circulation was assessed by 
measuring perfusion flow rate and vascular resistance. 
The perfusion flow rate was assessed continuously dur-
ing reperfusion (expressed as mL/min/g liver). Vascu-
lar resistance was defined as the ratio of  portal venous 
pressure to flow rate (expressed as mmHg/min/g liver/
mL)[26].
Glutamate dehydrogenase activity: The mitochondrial 
enzyme glutamate dehydrogenase (GLDH) was used as 
an indirect measure of  mitochondrial damage as previ-
ously reported[28]. 
Lipid peroxidation assay: Lipid peroxidation in the 
liver was used as an indirect measure of  the oxidative in-
jury induced by ROS. Lipid peroxidation was determined 
by measuring the formation of  malondialdehyde (MDA) 
with the thiobarbiturate reaction[28].
Determination of  nitrites and nitrates: Nitric oxide 
(NO) production by the liver was determined by measur-
ing tissue accumulation of  nitrites and nitrates, as previ-
ously reported[28].
Western blot analysis 
Liver tissue was homogenized as previously described[28]. 
Total protein was loaded in Laemmli buffer onto a 
SDS-polyacrylamide gel in a Mini Cell (Bio-Rad). The 
proteins were transferred to polyvinylidene difluoride 
membranes and blocked in 1 × phosphate buffered sa-
line (PBS)/0.05% Tween 20/5% non-fat dry milk. Mem-
branes were immunoblotted with antibodies directed 
against phospho-AMPK (adenosine monophosphate-
activated protein kinase) (Thr172), total AMPK, Beclin-1, 
and LCB3 (Cell Signaling Technology Inc, Beverly, Mas-
sachusetts); anti-endothelial NO synthase (eNOS) and 
heat shock protein (HSP) 70 (BD Transduction Labo-
ratories, Lexington, Kentucky); and β-Actin, actin, and 
heme oxygenase-1 (HO-1; Sigma Chemical, St. Louis, 
Missouri). The secondary antibody was added for 1 h and 
the membranes were developed using enhanced chemilu-
minescence reagents from Bio-Rad (Hercules, California) 
and quantified by scanning densitometry.
Zymography
Frozen tissue samples were homogenized with a lysis 
buffer and centrifuged as described elsewhere[30]. Super-
natants were used for extraction of  gelatinolytic activ-
ity with Gelatin-Sepharose 4B (Amersham Biosciences, 
Uppsala, Sweden). Extracted liver samples were used to 
perform gelatin zymography using gelatinase zymogra-
phy standards. The gels were stained in 0.1% amido black 
in a 1:3:6 ratio of  acetic acid:methanol:water for 30 min 
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Table 1  Composition of Ringer’s lactate solution
Ringer lactate solution
Composition Concentration (mg/100 mL)
NaCl 600
KCl   40
CaCl2.2H2O   27
NaC3H5O3 312
Osmolarity (mOsm/L) 277
pH 5.0-7
Table 2  Composition of the different rinse solutions: BS, 
BS+PEG35 at 1g/L (BS+PEG1) and BS+PEG35 at 5g/L (BS 
+ PEG5)
Composition (g/L) BS BS + PEG1 BS + PEG5
CaCl2.2H2O       1.3        1.3    1.3
KH2PO4     5     5 5
NaH2PO4   20   20   20
MgSO4.7H2O     5     5     5
Lactobionic acid 100 100 100
Raffinose   30   30   30
PEG 35 -     1     5
pH        7.4        7.4       7.4
Osmolarity (mOsm/L) 320 320 320
BS: Base solution; BS + PEG1: BS with PEG-35 at 1 g/L; BS + PEG5: BS 
with PEG-35 at 5 g/L.
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Statistical analysis
Data were expressed as mean ± SE, and were compared 
statistically by variance analysis, followed by the Student-
Newman-Keuls test (Graph Pad Prism software). P < 0.05 
was considered significant.
RESULTS
Liver injury
Effluent fluid was collected to determine ALT and AST 
levels after 2 h of  reperfusion as a predictor of  organ 
damage after cold IRI. Figure 1 shows the AST and ALT 
profiles of  the liver grafts subjected to washout with RLS, 
BS, and BS+PEG-35 solutions (Table 2). Use of  the BS 
solution supplemented with PEG-35 prevented AST and 
ALT release after 2 h of  reperfusion when compared 
to both the RLS and BS solutions. No differences were 
found when BS + PEG1 (1 g/L) and BS + PEG5 (5 g/L) 
solutions were compared. 
Liver function 
Liver function was assessed by measuring bile production 
and vascular resistance. As indicated in Figure 2A, a signif-
icant increase was observed in bile production after 2 h of  
reperfusion in liver grafts flushed with BS + PEG1 and 
BS + PEG5 rinse solutions when compared to RLS and 
BS alone. These results were consistent with a reduced 
vascular resistance after 2 h of  reperfusion, as shown by 
the profiling studies reported in Figure 2B. 
Oxidative stress and mitochondrial injury in the liver 
To evaluate the effect of  PEG-35 rinse solutions in oxi-
dative stress and mitochondrial damage, we measured 
levels of  MDA, a lipoperoxidation marker. We observed 
a significant MDA reduction with the PEG-35 rinse solu-
tions when compared to BS alone (Figure 3A). This pre-
ventive effect was more marked when compared to RLS. 
These results were consistent with liver mitochondrial 
and destained in the solvent, followed by a final wash in 
distilled water. Gelatinolytic enzymes were detected as 
transparent bands on the gel[30].
Confocal fluorescence microscopy
The liver was fixed, cryoprotected with sucrose, embed-
ded in optimal cutting temperature media, and frozen 
on a copper plate on dry ice. Cryosections (5 μm) were 
cut in a cryostat and post fixed in 4% buffered parafor-
maldehyde for 10 min, and then permeabilized with PBS 
containing 0.1% Triton X-100 and 1% bovine serum 
albumin (BSA) for 30 min. For actin visualization, the 
slides were incubated with tetramethylrhodamine-phal-
loidin (TRITC-phalloidin, Sigma; dilution 2 μmol/L) in 
PBS with 1% BSA and 0.2% Triton X-100 for 30 min. 
Slides were washed 3 times for 15 min with PBS. The last 
PBS wash included Hoechst 33342 (Invitrogen; dilution 
1 μmol/L). Finally, cryosections were mounted using 
Mowiol (Calbiochem).
Confocal images were acquired with a Leica TCS SP5 
laser scanning microscope (Leica Microsystems, Germany) 
equipped with a 63 × NA1.4 oil-immersion objective. 
Hoechst-33342 and Phalloidin-A555 images were acquired 
sequentially using an acousto-optical beam splitter with 405 
nm and 561 nm laser lines and emission detection ranges 
of  415-450 nm and 570-650 nm respectively. The confo-
cal pinhole was set at 1 Airy unit and when 3-dimensional 
reconstruction was required, stacks of  images every 0.3 
mm were acquired. The sinusoid circularity of  livers (based 
on Phalloidin staining) was quantified on ImageJ (Wayne 
Rasband, National Institute of  Health, United States) 
as 4π × [(Area)]/[(Perimeter)2]. Briefly, the red channel 
(phalloidin-A555 staining) was mean filtered (radius 1), 
before thresholding, conversion to a binary image, and 
inversion. Sinusoids were selected and circularity was 
measured (in 16 mm2 of  each sample). A value of  1.0 
indicated a perfect circle; as the value approached 0.0, an 
increasingly elongated shape was more likely.
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Figure 1  Alanine aminotransferase (A) and aspartate aminotransferase (B) levels in the perfusate of livers rinsed with different washout solutions (RLS, 
BS, BS + PEG1, and BS + PEG5) and subjected to 2 h of normothermic reperfusion. aP < 0.05 vs RLS; cP < 0.05 vs BS. Please see BS composition in Table 2. 
PEG: Polyethylene glycol; RLS: Ringer’s lactate solution; BS: Base solution; BS + PEG1: BS with PEG-35 at 1 g/L; BS + PEG5: BS with PEG-35 at 5 g/L. AST: Aspar-
tate aminotransferase; ALT: Alanine aminotransferase.
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damage measured by GLDH activity in liver perfusate at 
the end of  the 2-h reperfusion period. Livers rinsed with 
RLS showed the highest GLDH activity when compared 
to those rinsed with BS alone (Figure 3B). PEG-35 (ei-
ther 1 g/L or 5 g/L) added to BS significantly reduced 
GLDH levels when compared to RLS and BS alone. No 
differences were observed between the PEG-35 groups.
Cell signaling pathways implicated in liver protection
We evaluated the cytoprotective cell signaling pathways 
involved in liver grafts by assessing the effect of  PEG-35 
rinse solutions on AMPK phosphorylation. We found 
a significant increase in phosphorylated AMPK levels 
in liver grafts rinsed with PEG-35 containing solutions 
when compared to RLS and BS (Figure 4A). This was 
concomitant with increases in nitrite/nitrate levels and 
eNOS activation (Figures 4B and C).
In addition, we examined the effect of  PEG-35 rinse 
solutions on the induction of  heme oxygenase-1 (HO-1) 
and HSP70 (known cytoprotective proteins involved in 
the reduction of  liver damage after IRI). The highest 
HO-1 protein levels were observed in livers rinsed with 
PEG-35 solution when compared to RLS and BS alone. 
Major differences were observed between the 5 g/L 
and 1 g/L concentrations of  PEG-35 (Figure 5A). The 
HSP70 protein expression pattern was similar to that de-
scribed for HO-1 expression (Figure 5B).
Liver cytoskeleton alteration
Next, we evaluated the impact of  PEG-35 rinse solutions 
on liver cytoskeleton distribution by assessing changes in 
filamentous actin (F-actin) and globular actin (G-actin). 
Our results demonstrated that the greatest G-actin frac-
tion was observed in livers rinsed with the RLS when 
compared to BS and PEG-35 solutions (Figure 6). Con-
versely, the F-actin fraction was higher in the PEG-35 so-
lution than in either RLS or BS alone (Figure 6). This was 
consistent with the metalloproteinase (MMP) activation 
shown in Figure 7. In fact, we observed a significant re-
duction in MMP9 activity in livers flushed with PEG-35 
solutions when compared to those flushed only with RLS 
or BS. No differences were found between the PEG-35 
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Figure 2  Bile production and vascular resistance (A) in livers rinsed with different washout solutions (RLS, BS, BS + PEG1, and BS + PEG5) and subjected 
to 2 h of normothermic reperfusion (B). aP < 0.05 vs RLS; cP < 0.05 vs BS. PEG: Polyethylene glycol; RLS: Ringer’s lactate solution; BS: Base solution; BS + 
PEG1: BS with PEG-35 at 1 g/L; BS + PEG5: BS with PEG-35 at 5 g/L.
Figure 3  Hepatic malondialdehyde (A) and glutamate dehydrogenase (B) in livers rinsed with different washout solutions (RLS, BS, BS + PEG1, and BS + 
PEG5) and subjected to 2 h of normothermic reperfusion. aP < 0.05 vs RLS; cP < 0.05 vs BS. PEG: Polyethylene glycol; RLS: Ringer’s lactate solution; BS: Base 
solution; BS + PEG1: BS with PEG-35 at 1 g/L; BS + PEG5: BS with PEG-35 at 5 g/L. MDA: Malondialdehyde; GLDH: Glutamate dehydrogenase.
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solutions. In addition, we observed an increased MMP2 
activity only when BS was used. However, no differences 
were found between the PEG-35 solutions and RLS (Fig-
ure 7B). The alterations in the actin cytoskeleton resulted 
in changes in cell shape and adhesiveness: we observed 
sinusoidal shape changes in livers rinsed with RLS as op-
posed to a normal hexagonal morphology in livers rinsed 
with the PEG-35 solutions (Figure 8).
Liver autophagy
In liver grafts subjected to 24 h of  UW cold preservation 
and 2 h of  reperfusion, we evaluated the incidence of  
liver graft autophagy by measuring the levels of  estab-
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Figure 4  Phosphorylated adenosine monophosphate-activated protein 
kinase protein levels (A), e-NOS protein levels (B) and nitrites and nitrates 
(C) in livers flushed with different washout solutions (RLS, BS, BS + 
PEG1, and BS + PEG5) and subjected to 2 h of normothermic reperfusion. 
aP < 0.05 vs RLS; cP < 0.05 vs BS. PEG: Polyethylene glycol; RLS: Ringer’s 
lactate solution; BS: Base solution; BS + PEG1: BS with PEG-35 at 1 g/L; BS 
+ PEG5: BS with PEG-35 at 5 g/L. AMPK: Adenosine monophosphate protein 
kinase; eNOS: Endothelial nitric oxide synthase.
Figure 5  Heme oxygenase 1 (A) and heat shock protein 70 (B) protein 
levels in livers flushed with different washout solutions (RLS, BS, BS + 
PEG1, and BS + PEG5) and subjected to 2 h of normothermic reperfusion. 
aP < 0.05 vs RLS; cP < 0.05 vs BS; eP < 0.05 vs BS + PEG1. PEG: Polyeth-
ylene glycol; RLS: Ringer’s lactate solution; BS: Base solution; BS + PEG1: 
BS with PEG-35 at 1 g/L; BS + PEG5: BS with PEG-35 at 5 g/L. HO-1: Heme 
oxygenase 1.
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lished markers, Beclin-1 and LCB3. As evidenced in Fig-
ure 9, Beclin-1 and LCB3 levels fell significantly in livers 
washed with PEG-35 rinse solutions compared to those 
washed with either RLS or BS alone.
DISCUSSION
Several rinse solutions have been proposed for the ef-
ficient washout of  liver grafts before transplantation. In 
this paper we demonstrate that the washout step is neces-
sary for both the removal of  remaining preservation so-
lution, and also for protecting the liver graft against IRI. 
Following our experience in the use of  PEG-35 for fatty 
liver preservation[17,28,29], we have explored its use as a 
rinse solution. Due to the fact that PEG-35 is the oncotic 
agent at low concentrations in the IGL-1 preservation 
solution, we compared rinse solutions supplemented with 
PEG-35 at 1 g/L and 5 g/L. 
PEG polymers are water-soluble, biocompatible, non-
toxic materials that are commercially available at differ-
ent molecular weights[1,19]. PEG is approved for use in 
humans by the FDA, and its applications range from use 
as an excipient in drug formulations, cosmetics, and food 
preparations to use as a conjugating polymer for thera-
peutic protein delivery[31]. To date, the use of  PEG in 
preservation solution has been associated with several ad-
vantages, but it has not yet been tested in rinse solutions. 
In this study, we demonstrated that the PEG-35 rinse 
solution prevented liver injury after 2 h of  reperfusion 
when compared to the grafts flushed with either RLS 
or BS alone. This effective protection was concomitant 
with a subsequent improvement in hepatic function, as 
reflected by bile production[17] and a significant reduction 
in vascular resistance. These results are consistent with 
previous reports evidencing the protective role of  differ-
ent PEG molecules for organ preservation[16,20,28].
A growing body of  evidence indicates that mitochon-
drial dysfunction is a critical pathological process in liver 
IRI. Impaired mitochondrial function results in defective 
energy use and excessive reactive oxygen species gen-
eration[32]. Here we demonstrated that the addition of  
PEG-35 to a rinse solution prevented mitochondrial dam-
age and oxidative stress, when compared to either RLS 
or BS solutions. Our results are in line with previously 
reported data demonstrating the effective antioxidant role 
of  PEG, through the suppression of  lipid peroxidation, 
after rewarming cold-stored hepatocytes[33]. This preven-
tion was also accompanied by increases in HSP70 and 
HO-1 expression. Overexpression of  both HSPs, well 
known markers of  graft survival after transplantation[34], 
was more relevant for PEG-35 at 5 g/L when compared 
to 1 g/L suggesting that the higher concentration was 
more suitable for increasing liver graft tolerance to IRI. 
In our study, the PEG-35 rinse solution increased 
phosphorylated AMPK levels. AMPK is an enzyme invol-
ved in cellular energy balance that regulates the downs-
tream signaling pathways towards an energy-conserving 
state[35]. AMPK activation before or during organ preser-
vation helps to limit organ injury and maintain graft qua-
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Figure 6  Effects of washout on liver cytoskeleton: changes in filamentous 
actin (F-actin) and globular actin (G-actin) ratio in livers flushed with dif-
ferent washout solutions (RLS, BS, BS + PEG1, and BS + PEG5) and sub-
jected to 2 h of normothermic reperfusion. aP < 0.05 vs RLS; cP < 0.05 vs 
BS; eP < 0.05 vs BS + PEG1. PEG: Polyethylene glycol; RLS: Ringer’s lactate 
solution; BS: Base solution; BS + PEG1: BS with PEG-35 at 1 g/L; BS + PEG5: 
BS with PEG-35 at 5 g/L.
Figure 7  Effects of washout on metalloproteinase 9 (A) and metallopro-
teinase 2 (B) activity in livers flushed with different washout solutions 
(RLS, BS, BS + PEG1, and BS + PEG5) and subjected to 2 h of normother-
mic reperfusion. aP < 0.05 vs RLS; cP < 0.05 vs BS; eP < 0.05 vs BS + PEG1. 
PEG: Polyethylene glycol; RLS: Ringer’s lactate solution; BS: Base solution; BS 
+ PEG1: BS with PEG-35 at 1 g/L; BS + PEG5: BS with PEG-35 at 5 g/L. MMP: 
Metalloproteinase.
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lity[36,37]. We have previously reported that AMPK inducers 
ameliorated fatty liver graft preservation when added to 
preservation solutions[38]. We have now demonstrated that 
PEG-35 rinse solutions contribute to AMPK activation; 
furthermore, rinsing liver grafts with solutions containing 
PEG-35 resulted in activation of  constitutive eNOS and 
subsequent NO generation[36,37]. NO is a gaseous vaso-
dilator that protects liver endothelial cells against IRI[39]. 
Its activation is consistent with the observed decreases in 
vascular resistance after washing out with PEG-35 rinse 
solutions, which are associated with NO generation and 
contribute to preventing microcirculation alterations after 
liver graft revascularization.
Changes in cytoskeletal structure and cell morphology 
occur in the liver following IRI that can ultimately lead to 
graft dysfunction[40-42]. Recently, it has been reported that 
PEG contributes to the regulation of  endothelial cell bar-
rier by rearranging the actin cytoskeleton[43]. Subcellular 
F-actin is an important component of  the cytoskeleton, 
and the balance between F-actin and monomeric G-actin 
largely determines the functional outcome. It is important 
to note that F-actin forms microfilaments in liver cells, 
which are involved in intracellular processes, the main-
tenance of  cell morphology, and bile canalicular motility 
necessary for bile secretion[42,44,45]. With this in mind, we 
explored the effects of  PEG-35 rinse solutions on the 
liver cytoskeleton by measuring F- and G-actin distribu-
tion and ultrastructural changes by confocal microscopy. 
Livers subjected to washout with RLS and BS showed 
low F-actin content reflecting actin cytoskeletal deran-
gement, probably associated with ischemia. In contrast, 
PEG-35 use reversed the loss of  F-actin by increasing its 
polymerization, as reflected by an increased F-actin/G-ac-
tin ratio. This confirms the protective effect of  PEG-35 
rinse solution in preventing the loss of  cell integrity du-
ring IRI.
Extracellular matrix turnover, influenced by MMP9 
and MMP2, occurs during tissue remodeling after IRI[46,47]. 
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Figure 8  Confocal microscopy findings  of hepatocyte and sinusoidal shape when livers were rinsed with different rinse solutions (RLS, BS + PEG5). RLS: 
Ringer’s lactate solution; BS + PEG5: Base Solution with PEG-35 at 5 g/L.
Figure 9  Effects of washout solution on liver graft autophagy: Beclin 1 (A) and LCB3 (B) protein levels in liver rinsed with different washout solutions (RLS, 
BS, BS + PEG1, and BS + PEG5). aP < 0.05 vs RLS; cP < 0.05 vs BS; eP < 0.05 vs BS + PEG1. PEG: Polyethylene glycol; RLS: Ringer’s lactate solution; BS: Base 
solution; BS + PEG1: BS with PEG-35 at 1 g/L; BS + PEG5: BS with PEG-35 at 5 g/L.
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In experimental models of  hepatic IRI, inhibiting MMP2 
and MMP9 has also reduced tissue damage[30,48]. In this 
study, we demonstrated that the PEG-35 rinse solutions 
inhibited MMP9 activity, suggesting cytoskeletal stability 
compared to either RLS or BS. This fact is consistent 
with the reduction of  morphological alterations on 
confocal microscopy. Specifically, we observed that liver 
graft cells rinsed with RLS or BS acquired a slightly de-
formed round shape, while those washed with PEG-35 
rinse solutions demonstrated normal morphology.
Our results suggest that cytoskeletal integrity is better 
preserved by the presence of  PEG-35 in rinse solutions. 
This is consistent with another study where high-mole-
cular-weight PEG physically bound to cardiac myocyte 
plasma membranes was observed to activate signaling 
pathways that protect against hypoxia-reoxygenation as-
sociated cell death[49]. It has also been reported that PEG 
joins various regulatory elements of  the endothelial cell 
barrier, thus providing beneficial effects on the architec-
ture of  the endothelial cytoskeleton[43]. 
Autophagy is associated with the turnover of  long-
lived proteins, cytosolic components, or damaged organel-
les. It is a highly regulated process involving the formation 
and delivery of  autophagosomes to lysosomes for degra-
dation. Based on growing evidence linking autophagy to 
IRI[50-52], we evaluated its potential involvement during the 
liver graft washout process. Indeed, autophagy has long 
been recognized to occur in organs under stress condi-
tions such as IRI[52,53], although its precise role remains 
unclear and controversial. Although we know that the ac-
tivation of  autophagy during ischemia is essential for cell 
survival and maintaining organ function, through AMPK 
dependent mechanisms, its role during reperfusion could 
be detrimental[52,54,55]. Autophagy in reperfusion is accom-
panied by a robust up-regulation of  Beclin-1, which in 
turn is exacerbated by the generation of  reactive oxygen 
species, leading to a massive degradation of  vital molecu-
les and autophagic cell death[55,56].
In this study, we demonstrated that liver graft was-
hout using a rinse solution containing PEG-35 prevented 
liver autophagy. This is demonstrated through diminished 
Beclin-1 and LC3B levels, similarly to that reported for 
post-conditioning in a rat brain model[57]. The data re-
ported here are consistent with studies carried out by 
Gotoh et al[58], who implicated autophagy in the initiation 
of  graft dysfunction after rat liver transplantation. Thus, 
we can speculate that the prevention of  mitochondrial 
damage and ROS production by PEG-35 could explain 
the decreases in Beclin-1 and LC3B after liver graft was-
hout. The overall benefits of  using PEG-35 as a rinse 
solution are summarized in Figure 10.
In conclusion, we have demonstrated that the use 
of  a new rinse solution containing PEG-35 protects rat 
liver grafts against IRI and it could therefore be a useful 
clinical tool for increasing liver graft protection against 
reperfusion injury.
ACKNOWLEDGMENTS
We are grateful to the Language Advisory Service of  the 
University of  Barcelona for revising the English text.
COMMENTS
Background
Ischemia-reperfusion injury (IRI) is a determinant factor of graft function during 
and after liver transplantation. IRI is a complex process accompanied by oxida-
tive stress, loss of cell membrane integrity, and cell death. Liver graft washout 
prior to revascularization is an obligatory step to remove any remaining preser-
vation solution; however, this practice is dependent on individual surgical prac-
tices. Liver graft washout strategies are not standardized and have not been 
investigated in detail. Here, the authors propose a new rinse solution containing 
polyethylene glycol (PEG) 35 as suitable for liver graft protection against IRI. In 
addition, the underlying mechanisms are investigated.
Research frontiers
PEG is a non-toxic, water soluble polymer that has been associated with 
beneficial effects after various insults, including IRI. PEG is known to decrease 
reactive oxygen species, to protect liver mitochondria, to protect against cell 
death, and to help preserve cell membrane integrity. The presence of PEG-35 
(35000 k-daltons) in the novel Institut Georges Lopez 1 preservation solution 
(as an oncotic agent) has been associated with the prevention of hepatic IRI. 
The benefits are due, in part, to adenosine monophosphate protein kinase and 
endothelial nitric oxide synthase activation. Thus, the authors added PEG-35 to 
a rinse solution to evaluate the potential benefits in washing-out and increased 
graft protection against IRI.
Innovations and breakthroughs
The authors provide evidence that washing out the liver grafts prior to reperfu-
sion with a rinse solution that contains PEG-35 is an effective tool for providing 
a more effective protection against IRI. This is confirmed by decreases in hepa-
tic injury and oxidative stress, ameliorated hepatic function, and more efficient 
preservation of liver endothelial integrity.
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Figure 10  Benefits of Polyethylene glycol-35 washout solution. PEG: Poly-
ethylene glycol; AMPK: Adenosine monophosphate-activated protein kinase; 
MMP: Metalloproteinase; NO: Nitric oxide.
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Applications
Liver graft washout with a PEG-35 rinse solution is a useful strategy for efficient 
graft rinse and provides superior prevention before graft revascularization in 
clinical practice.
Terminology
Rinse solution is used for removing the remaining preservation solution and 
any toxic agents produced during cold storage of the graft. The use of rinse 
solution favors the most suitable graft revascularization and survival after 
transplantation.
Peer review
In this study, the authors studied a new rinse solution containing PEG-35 for 
preventing IRI in the liver graft. Using biochemical determinations, Western 
Blot Analysis, zymography and confocal fluorescence microscopy, they studied 
the function of PEG-35 in the processes of liver injury, liver function, oxidative 
stress, mitochondrial injury, liver cytoskeleton alteration and liver autophagy. 
While the role of PEG-35 in the protection against IRI is not surprising, I believe 
that there are merits in this study because it may give some cues for future 
research and clinical application in LT.
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